Next 10 |
home / stock / chgcf / chgcf news
2024-11-13 10:05:00 ET Summary Global markets advanced, with interest rate-sensitive sectors leading due to changes in monetary conditions; US and European central banks cut rates, while Japan hiked unexpectedly. China's stimulus package boosted its market by over 20%, benefiting ...
2024-11-06 12:00:00 ET Summary Global markets advanced, with interest rate-sensitive sectors leading due to changing monetary conditions; US and European central banks cut rates, while Japan hiked unexpectedly. China's stimulus package boosted its market, leading to a 20% rise in ...
2024-10-25 16:34:04 ET Chugai Pharmaceutical Co., Ltd. (CHGCF) Q3 2024 Earnings Conference Call October 25, 2024, 5:00 AM ET Company Participants Kae Miyata - Corporate Communications Department Osamu Okuda - President and CEO Tsukasa Kusano - Executive Vice Pres...
2024-08-29 23:40:00 ET Summary The International Developed Markets Equity composite rose 0.1% gross of fees in the quarter, slightly ahead of the 0.4% decline for the MSCI World ex US Index. International developed equity markets fell modestly, with Health Care gains offset by dec...
2024-08-29 09:20:00 ET Summary The International Equity ADR composite rose 0.7% gross of fees in the quarter, not far behind the 1.2% gain for the MSCI All Country World ex US Index. International equity markets saw mixed performance, with strong returns in IT, particularly semico...
2024-08-29 00:50:00 ET Summary The International Equity composite rose 0.4% gross of fees in the quarter, not far behind the 1.2% gain for the MSCI All Country World ex US Index. International equity markets showed mixed performance, with strong gains in IT and semiconductors offs...
2024-07-31 09:50:00 ET Summary Invesco Developing Markets Fund Class A shares underperformed the MSCI EM Index. Emerging markets equities delivered positive returns in the second quarter, outperforming US, developed market and global equities. We believe emerging market equiti...
2024-07-27 08:42:05 ET Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2024 Earnings Conference Call July 24, 2024 04:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and Chief Executive Officer Tsukasa Kusano - Execu...
2024-04-24 23:40:02 ET Chugai Pharmaceutical Co., Ltd. (CHGCF) Q1 2024 Earnings Conference Call April 24, 2024 5:00 AM ET Company Participants Kae Miyata - Head of Corporate Communications Osamu Okuda - President and Chief Executive Officer Tsukasa Kusano - Execu...
2024-03-21 07:00:09 ET More on Argenx SE argenx SE (ARGX) Q4 2023 Earnings Call Transcript argenx: Upgrading To 'Strong Buy' On Vyvgart's Q4 Sales, Empasiprubart Data, Pipeline Expansion Argenx SE GAAP EPS of -$1.68 misses by $0.30, revenue of $374M beats by $10.28M ...